SequelSEC

INTUITIVE SURGICAL INC ISRG

Orthopedic, Prosthetic & Surgical Appliances & Supplies · CIK 0001035267 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$11.03B
Fiscal year ended 2026-06-30
Operating income
$3.45B
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

INTUITIVE SURGICAL INC (ISRG) reported revenue of $11.03B and net income of $3.14B for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from INTUITIVE SURGICAL INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies.

Income

INTUITIVE SURGICAL INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$11.03B
Cost of revenue$3.68B
Gross profit$7.36B
Operating income$3.45B
Net income$3.14B
Research & development$1.41B
Weighted-average diluted sharesUnavailable
Pretax income$3.81B
Income tax expense$647.90M
Diluted EPSUnavailable
Selling, general & administrative$2.49B
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

INTUITIVE SURGICAL INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$2.76B
Total assets$20.88B
Current assets$9.54B
Total liabilities$2.58B
Current liabilities$1.92B
Total equity incl. NCI$18.30B
Temporary (mezzanine) equityUnavailable
Inventory$2.03B
Accounts receivable$1.67B
Goodwill$580.60M
Long-term debtUnavailable
Accounts payable$277.20M

Cash flow

INTUITIVE SURGICAL INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$3.71B
Capital expendituresUnavailable
Investing cash flow-$749.50M
Financing cash flow-$3.62B
Net change in cash-$640.80M
Stock-based compensation$826.20M
Common dividends paidUnavailable
Common share repurchases$3.56B
Depreciation & amortizationUnavailable

Derived

INTUITIVE SURGICAL INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin66.7%
Operating margin31.3%
FCF marginUnavailable
SBC / revenue7.5%
Current ratio4.96x
Revenue YoY growth20.7%
Net margin28.4%
R&D / revenue12.8%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rate17.0%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ISRG in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-07-21View SEC filing
10-Q · Filed 2026-04-22View SEC filing
10-K · Filed 2026-02-03View SEC filing
10-Q · Filed 2025-10-22View SEC filing
10-Q · Filed 2025-07-23View SEC filing
10-Q · Filed 2025-04-23View SEC filing

Companies in the same industry

ALGN APT AVR BBLG CDRE COCH ENOV ESTA EW FEED INGN LAKE

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.